178 related articles for article (PubMed ID: 28639693)
1. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693
[TBL] [Abstract][Full Text] [Related]
2. Multiple electrode aggregometry and thromboelastography in thrombocytopenic patients with haematological malignancies.
Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
Blood Transfus; 2019 May; 17(3):181-190. PubMed ID: 30747706
[TBL] [Abstract][Full Text] [Related]
3. Thromboelastography (TEG®) compared with total platelet count in thrombocytopenia haematological malignancy patients with bleeding: a pilot observational study.
Kasivisvanathan R; Koutra M; Rooms M; Black E; Desai L; Mallett SV; Rao-Baikady R
Transfus Med; 2015 Oct; 25(5):307-12. PubMed ID: 26132501
[TBL] [Abstract][Full Text] [Related]
4. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
[TBL] [Abstract][Full Text] [Related]
5. Benefits of Thromboelastography and Thrombin Generation Assay for Bleeding Prediction in Patients With Thrombocytopenia or Hematologic Malignancies.
Kim SY; Gu JY; Yoo HJ; Kim JE; Jang S; Choe S; Koh Y; Kim I; Kim HK
Ann Lab Med; 2017 Nov; 37(6):484-493. PubMed ID: 28840985
[TBL] [Abstract][Full Text] [Related]
6. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass.
Essell JH; Martin TJ; Salinas J; Thompson JM; Smith VC
J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):410-5. PubMed ID: 8400095
[TBL] [Abstract][Full Text] [Related]
7. Thromboelastography in guiding preventive platelet transfusion in patients with haematologic diseases.
Wei YH; Miao ZX; Guo XJ
Int J Lab Hematol; 2022 Oct; 44(5):945-951. PubMed ID: 35748054
[TBL] [Abstract][Full Text] [Related]
8. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
Vinholt PJ; Alnor A; Nybo M; Hvas AM
Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
[TBL] [Abstract][Full Text] [Related]
9. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both?
Karlsson O; Jeppsson A; Hellgren M
Int J Obstet Anesth; 2014 Feb; 23(1):10-7. PubMed ID: 24342222
[TBL] [Abstract][Full Text] [Related]
10. Impact of 6 % hydroxyethyl starch (HES) 130/0.4 on the correlation between standard laboratory tests and thromboelastography (TEG®) after cardiopulmonary bypass.
Hans GA; Hartstein G; Roediger L; Hubert B; Peters P; Senard M
Thromb Res; 2015 May; 135(5):984-9. PubMed ID: 25769493
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of thromboelastography and routine coagulation tests for evaluation of blood coagulation function in patients].
Chen GY; Ou Yang XL; Wu JH; Wang LH; Yang JH; Gu LN; Lu ZJ; Zhao XZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):546-51. PubMed ID: 25948222
[TBL] [Abstract][Full Text] [Related]
12. The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children.
Moganasundram S; Hunt BJ; Sykes K; Holton F; Parmar K; Durward A; Murdoch IA; Austin C; Anderson D; Tibby SM
Anesth Analg; 2010 Apr; 110(4):995-1002. PubMed ID: 20142345
[TBL] [Abstract][Full Text] [Related]
13. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies.
Gatt A; Bonello F; Buttigieg R; Debono S; Brincat P; Grima C; Gatt P; Lofaro T; Laspina S
Blood Transfus; 2014 Oct; 12(4):479-84. PubMed ID: 24960660
[TBL] [Abstract][Full Text] [Related]
15. CREST: clinical bleeding and risk evaluation in hematology-oncology patients: a systematic review and meta-analysis of thromboelastography's role.
Khoo CEH; Long MH; Shi L; Guo L; Hee HI
Blood Coagul Fibrinolysis; 2022 Oct; 33(7):351-363. PubMed ID: 35946467
[TBL] [Abstract][Full Text] [Related]
16. The Value of Thromboelastography for Bleeding Risk Prediction in Hematologic Diseases.
He Y; Xin X; Geng Y; Tang N; Zhou J; Li D
Am J Med Sci; 2016 Nov; 352(5):502-506. PubMed ID: 27865298
[TBL] [Abstract][Full Text] [Related]
17. Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura?
Gunduz E; Akay OM; Bal C; Gulbas Z
Platelets; 2011; 22(7):516-20. PubMed ID: 21557684
[TBL] [Abstract][Full Text] [Related]
18. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
Stanworth SJ; Dyer C; Casbard A; Murphy MF
Vox Sang; 2006 Jul; 91(1):63-9. PubMed ID: 16756603
[TBL] [Abstract][Full Text] [Related]
20. The role of thromboelastography in predicting bleeding risk and guiding the administration of platelet transfusions in hematological patients: a cohort study.
Xin X; Liu Z; Jian C; Tian M; Fang J; Sun H; Zhou J; Li D
Ann Hematol; 2016 Jun; 95(7):1163-8. PubMed ID: 27068407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
